Diabetes drug, metformin, lowers risk of heart disease deaths better than sulfonylureas

Posted by on April 19, 2016 12:17 pm
Categories: health

A new analysis of 204 studies involving more than 1.4 million people suggests that metformin, the most frequently prescribed stand-alone drug for type 2 diabetes, reduces the relative risk of a patient dying from heart disease by about 30 to 40 percent compared to its closest competitor drug, sulfonylurea.

Leave a Reply

Your email address will not be published. Required fields are marked *